N

Nichi-Iko Pharmaceutical Co Ltd
TSE:4541

Watchlist Manager
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Watchlist
Price: 0.0001 JPY Market Closed
Market Cap: 776 550.9T JPY
Have any thoughts about
Nichi-Iko Pharmaceutical Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Nichi-Iko Pharmaceutical Co Ltd

There are no price targets for Nichi-Iko Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Nichi-Iko Pharmaceutical Co Ltd Competitors:
Price Targets
UCB
Ucb SA
2% Upside
TARS
Tarsus Pharmaceuticals Inc
22% Upside
2005
SSY Group Ltd
90% Upside
4016
Middle East Pharmaceutical Industries Company SJSC
10% Upside
600380
Joincare Pharmaceutical Group Industry Co Ltd
25% Upside
603566
Pulike Biological Engineering Inc
11% Upside
JNJ
Johnson & Johnson
23% Upside
CLSD
Clearside Biomedical Inc
596% Upside

Revenue
Forecast

Revenue Estimate
Nichi-Iko Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Nichi-Iko Pharmaceutical Co Ltd's revenue is 7%. The projected CAGR for the next 3 years is 7%.

7%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Nichi-Iko Pharmaceutical Co Ltd

Operating Income forecast
is not available for
Nichi-Iko Pharmaceutical Co Ltd

Net Income
Forecast

Net Income Estimate
Nichi-Iko Pharmaceutical Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-92%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Nichi-Iko Pharmaceutical Co Ltd's stock price target?
Not Available

Nichi-Iko Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Nichi-Iko Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for Nichi-Iko Pharmaceutical Co Ltd's revenue is 7%. The projected CAGR for the next 3 years is 7%.

Back to Top